![William Fodor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: - $ op 31-05-2026
William Fodor is Chief Scientific Officer at Harvard Apparatus Regenerative Technology, Inc. since 2017.
Former roles include Chief Executive Officer at GlyGenix Therapeutics, Inc., Senior Director-Tissue Engineering at Alexion Pharmaceuticals, Inc., Senior Director-Product Development at ViaCell, Inc. from 2006 to 2008, and Associate Professor at the University of Connecticut from 2002 to 2005.
Education includes a doctorate from The Ohio State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 21-04-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Hoofd Techniek/Wetenschap/O&O | 01-07-2017 |
| Bedrijven | Functie | Einde |
|---|---|---|
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Corporate Officer/Principal | 01-07-2008 |
University of Connecticut
 University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-12-2005 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
GlyGenix Therapeutics, Inc.
 GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Algemeen Directeur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 6 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology Provides and develops cellular medicine for the treatment of diseases | Health Technology |
Harvard Apparatus Regenerative Technology, Inc.
 Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Connecticut
University of Connecticut Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlyGenix Therapeutics, Inc.
GlyGenix Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic products for the treatment of cure metabolic disorders | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
Kies MarketScreener 
